MicroPort CardioFlow Medtech Co., Ltd (HKG: 2160), a spin-off of China-based MicroPort Scientific Corp (HKG: 0853), has announced that a conditional agreement has been reached to acquire a 51% stake in fellow Chinese firm La Ronda for a cash consideration of RMB 141 million (USD 20 million). La Ronda, based in Shanghai, specializes in the manufacturing of left atrial appendage devices.
Established in 2019, La Ronda is a high-tech medical equipment company with a product pipeline that includes the AnchorMan left atrial appendage occluder and the AnchorMan left atrial appendage guidance system. CardioFlow, which operates in various medical fields including cardiovascular, orthopedic, cardiac rhythm management, large arteries and peripheral blood vessels, neurovascular, heart valves, and surgical robots, plans to fund the acquisition through net proceeds from global financing activities.- Flcube.com
